**Core Concept:** Leprosy is a chronic infectious disease caused by Mycobacterium leprae or Mycobacterium lepromatosis. It primarily affects the skin, peripheral nerves, eyes, nose, and upper respiratory tract. The disease can lead to severe disabilities and disfigurement if left untreated. Drug therapy plays a crucial role in the management of leprosy.

**Why the Correct Answer is Right:**
The correct answer, **Dapsone (DDS)**, is a diaminodiphenyl sulfone antibiotic, which belongs to the group of drugs known as thiol antibiotics. Dapsone is a potent inhibitor of bacterial DNA synthesis and has a bacteriostatic effect on M. leprae. In the WHO-recommended multidrug therapy (MDT) for leprosy, dapsone is combined with clofazimine and rifampicin.

**Why Each Wrong Option is Incorrect:**
A. **Clofazimine (CLF)** is a bacteriostatic drug that interferes with bacterial DNA synthesis and is part of the WHO-recommended multidrug therapy (MDT) for leprosy, but it is not the most common drug used in leprosy treatment.

B. **Rifampicin (RIF)** is an antibiotic that is part of the WHO-recommended multidrug therapy (MDT) for leprosy, but it is not the most common drug used in leprosy treatment.

C. **Methotrexate (MTX)** is an immunosuppressive drug used in the treatment of autoimmune diseases and cancer, not leprosy.

**Clinical Pearl:**
Multidrug therapy (MDT) is the standard treatment for leprosy, which includes dapsone, clofazimine, and rifampicin. This combination therapy is essential to prevent drug resistance and improve treatment outcomes. Dapsone is the cornerstone of MDT, ensuring bacterial DNA synthesis inhibition and reducing the risk of drug resistance. However, it is essential to understand that dapsone is not the only drug used in leprosy treatment, but it is the most common drug used.

**Correct Answer: Dapsone (DDS)** is the most common drug used in leprosy treatment, as it is part of the WHO-recommended multidrug therapy (MDT) along with clofazimine and rifampicin. Dapsone has a bacteriostatic effect by inhibiting bacterial DNA synthesis, which is crucial in preventing drug resistance in leprosy patients.